Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure


Lim, Sean H. and Johnson, Peter W.M. (2011) Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure Nature Reviews Clinical Oncology, 8, (11), pp. 634-636. (doi:10.1038/nrclinonc.2011.137). (PMID:21894205).

Download

Full text not available from this repository.

Description/Abstract

The combination of doxorubicin, bleomycin, vincristine and dacarbazine (ABVD) has emerged as a standard of care in advanced-stage Hodgkin lymphoma over the past four decades. Clinicians treating patients with cancer frequently walk a tightrope where the requirements of efficacy have to be balanced against the morbidity caused by the treatment.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1038/nrclinonc.2011.137
ISSNs: 1759-4774 (print)
Subjects:
Organisations: Cancer Sciences
ePrint ID: 340837
Date :
Date Event
November 2011Published
Date Deposited: 04 Jul 2012 10:35
Last Modified: 17 Apr 2017 16:51
Further Information:Google Scholar
URI: http://eprints.soton.ac.uk/id/eprint/340837

Actions (login required)

View Item View Item